BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1536952)

  • 21. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
    Akashi K; Taniguchi S; Nagafuji K; Harada M; Shibuya T; Hayashi S; Gondo H; Niho Y
    Leuk Res; 1993 Jul; 17(7):549-55. PubMed ID: 8326735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.
    Andreeff M; Jiang S; Zhang X; Konopleva M; Estrov Z; Snell VE; Xie Z; Okcu MF; Sanchez-Williams G; Dong J; Estey EH; Champlin RC; Kornblau SM; Reed JC; Zhao S
    Leukemia; 1999 Nov; 13(11):1881-92. PubMed ID: 10557066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages.
    Birg F; Courcoul M; Rosnet O; Bardin F; Pébusque MJ; Marchetto S; Tabilio A; Mannoni P; Birnbaum D
    Blood; 1992 Nov; 80(10):2584-93. PubMed ID: 1384791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes.
    Miranda RN; Briggs RC; Shults K; Kinney MC; Jensen RA; Cousar JB
    Hum Pathol; 1999 Sep; 30(9):1040-9. PubMed ID: 10492038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of VIM-2 and SSEA-1 glycoconjugate epitopes among human leukocytes and leukemia cells.
    Macher BA; Beckstead JH
    Leuk Res; 1990; 14(2):119-30. PubMed ID: 1690317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation.
    Morosetti R; Park DJ; Chumakov AM; Grillier I; Shiohara M; Gombart AF; Nakamaki T; Weinberg K; Koeffler HP
    Blood; 1997 Oct; 90(7):2591-600. PubMed ID: 9326225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
    Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
    Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
    Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
    van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
    Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
    Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia.
    Yamasaki H; Era T; Asou N; Sanada I; Matutes E; Yamaguchi K; Takatsuki K
    Leukemia; 1995 Jul; 9(7):1147-53. PubMed ID: 7630188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotyping of blasts in refractory anaemia with excess of blasts.
    Oertel J; Kleiner S; Huhn D
    Br J Haematol; 1993 Jun; 84(2):305-9. PubMed ID: 7691147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor alpha down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia.
    Bergamaschi G; Carlo-Stella C; Cazzola M; De Fazio P; Pedrazzoli P; Peverali FA; Della Valle G
    Leukemia; 1990 Jun; 4(6):426-30. PubMed ID: 2359342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.
    Aichberger KJ; Mayerhofer M; Krauth MT; Skvara H; Florian S; Sonneck K; Akgul C; Derdak S; Pickl WF; Wacheck V; Selzer E; Monia BP; Moriggl R; Valent P; Sillaber C
    Blood; 2005 Apr; 105(8):3303-11. PubMed ID: 15626746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
    Lanza F; Bi S; Castoldi G; Goldman JM
    Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.